MOAVERO, ROMINA
 Distribuzione geografica
Continente #
NA - Nord America 21.265
AS - Asia 3.461
EU - Europa 2.344
SA - Sud America 491
Continente sconosciuto - Info sul continente non disponibili 382
AF - Africa 61
OC - Oceania 26
Totale 28.030
Nazione #
US - Stati Uniti d'America 21.114
SG - Singapore 1.774
IT - Italia 654
CN - Cina 443
BR - Brasile 386
RU - Federazione Russa 329
HK - Hong Kong 307
VN - Vietnam 284
IE - Irlanda 242
DE - Germania 238
UA - Ucraina 225
FR - Francia 161
BD - Bangladesh 154
GB - Regno Unito 153
KR - Corea 133
JP - Giappone 101
FI - Finlandia 85
NL - Olanda 75
CA - Canada 66
IN - India 57
SE - Svezia 53
TW - Taiwan 47
PL - Polonia 46
AR - Argentina 43
MX - Messico 31
AT - Austria 29
AU - Australia 26
ID - Indonesia 25
IQ - Iraq 21
TR - Turchia 21
CO - Colombia 16
EC - Ecuador 16
ZA - Sudafrica 16
ES - Italia 15
CR - Costa Rica 11
MA - Marocco 11
MY - Malesia 10
PH - Filippine 10
SA - Arabia Saudita 10
UZ - Uzbekistan 10
VE - Venezuela 10
TH - Thailandia 9
CZ - Repubblica Ceca 8
EG - Egitto 8
JM - Giamaica 8
KE - Kenya 8
PK - Pakistan 8
DZ - Algeria 7
NI - Nicaragua 7
TT - Trinidad e Tobago 7
AE - Emirati Arabi Uniti 6
PE - Perù 6
SV - El Salvador 6
BG - Bulgaria 5
EU - Europa 5
JO - Giordania 5
KZ - Kazakistan 5
PY - Paraguay 5
RO - Romania 5
UY - Uruguay 4
BE - Belgio 3
BO - Bolivia 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
LB - Libano 3
PA - Panama 3
BH - Bahrain 2
CL - Cile 2
ET - Etiopia 2
FO - Isole Faroe 2
GR - Grecia 2
HN - Honduras 2
IL - Israele 2
IR - Iran 2
LK - Sri Lanka 2
NO - Norvegia 2
NP - Nepal 2
SM - San Marino 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
HT - Haiti 1
KG - Kirghizistan 1
KM - Comore 1
KN - Saint Kitts e Nevis 1
LC - Santa Lucia 1
LT - Lituania 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MR - Mauritania 1
NG - Nigeria 1
Totale 27.647
Città #
Woodbridge 5.442
Wilmington 4.709
Houston 3.817
Singapore 892
Fairfield 743
San Jose 612
Ashburn 576
Ann Arbor 413
Chandler 316
Seattle 308
Hong Kong 301
Council Bluffs 242
Cambridge 232
Dublin 230
Jacksonville 191
Medford 178
Santa Clara 165
Rome 153
Beijing 152
New York 137
Los Angeles 117
The Dalles 104
Dallas 100
Dearborn 97
Ho Chi Minh City 90
Lawrence 88
Tokyo 80
Buffalo 78
Hanoi 77
Chicago 74
Lauterbourg 65
Moscow 58
Taipei 42
Milan 38
Menlo Park 36
Norwalk 36
San Diego 36
São Paulo 34
Kraków 33
Munich 29
North Bergen 29
London 28
Nuremberg 25
Salt Lake City 25
Miami 23
Atlanta 22
Phoenix 22
Denver 20
Haiphong 20
Redondo Beach 20
Jakarta 18
Lappeenranta 18
Orem 18
Helsinki 17
Brooklyn 16
Montreal 16
Mülheim 16
Frankfurt am Main 15
Amsterdam 14
Chennai 14
Del Norte 14
Elk Grove Village 14
Redwood City 14
Rio de Janeiro 14
Boardman 12
Bologna 12
Melbourne 12
Warsaw 12
Lancaster 11
Mexico City 11
Naples 11
San Francisco 11
Seoul 11
Stockholm 11
Vienna 11
Curitiba 10
San José 10
Shanghai 10
Villa Adelina 10
Boston 9
Da Nang 9
Johannesburg 9
Kuala Lumpur 9
Mumbai 9
Saint Augustine 9
Turin 9
Catania 8
Genoa 8
Manchester 8
Modena 8
New Delhi 8
Paris 8
Philadelphia 8
Redmond 8
Ribeirão Preto 8
Sterling 8
Sydney 8
Tampa 8
Tashkent 8
University Center 8
Totale 21.913
Nome #
Current role of perampanel in pediatric epilepsy 550
Neurological and neuropsychiatric aspects of tuberous sclerosis complex. 517
The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions 478
Cognitive development in females with PCDH19 gene-related epilepsy 475
Peri-ictal water drinking: a rare automatic behaviour in temporal lobe epilepsy 459
mTOR Inhibitors in Tuberous Sclerosis Complex. 456
Current role of melatonin in pediatric neurology: Clinical recommendations 454
Genotype/Phenotype Correlations in Tuberous Sclerosis Complex. 450
Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders. 443
Timing and clinical characteristics of topiramate-induced psychosis in a patient with epilepsy and tuberous sclerosis 442
Mammalian Target of Rapamycin Inhibitors and Life-Threatening Conditions in Tuberous Sclerosis Complex. 440
Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy 440
Is mTOR inhibition a systemic treatment for tuberous sclerosis? 432
The neurobiology of attention deficit/hyperactivity disorder. 431
Reduction in retinal nerve fiber layer thickness in tuberous sclerosis complex. 431
Long-term follow-up in children with benign convulsions associated with gastroenteritis 428
Clinical Reasoning: A girl presenting with stiffness episodes during sleep, café-au-lait spots, and flecked retina 427
Syndromic autism: Causes and pathogenetic pathways 422
Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC 422
Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex 417
The Challenge of Pharmacotherapy in Children and Adolescents with Epilepsy-ADHD Comorbidity 415
Abnormal parieto-motor connectivity in Tuberous Sclerosis Complex 413
Metastatic Group 3 Medulloblastoma in a Patient With Tuberous Sclerosis Complex: Case Description and Molecular Characterization of the Tumor 413
Risk and Protective Environmental Factors Associated with Autism Spectrum Disorder: Evidence-Based Principles and Recommendations 412
Headache and attention deficit and hyperactivity disorder in children: common condition with complex relation and disabling consequences 411
Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines 406
Ketogenic diet in early myoclonic encephalopathy due to non ketotic hyperglycinemia 403
Combined targeted treatment in early onset epilepsy associated with tuberous sclerosis 398
Pancreatic neuroendocrine tumor in a child with a tuberous sclerosis complex 2 (TSC2) mutation 396
Autism spectrum disorders in tuberous sclerosis: pathogenetic pathways and implications for treatment. 395
White matter disruption is associated with persistent seizures in tuberous sclerosis complex 393
Everolimus Alleviates Obstructive Hydrocephalus due to Subependymal Giant Cell Astrocytomas 393
Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis. 392
Rufinamide efficacy and safety as adjunctive treatment in children with focal drug resistant epilepsy: The first Italian prospective study 391
The neurobiological basis of ADHD. 389
Tubers, epileptogenic foci, and epileptogenic networks in tuberous sclerosis. 387
The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective 383
Epilepsy secondary to tuberous sclerosis: lessons learned and current challenges. 381
Attention deficit hyperactivity disorder in children with epilepsy. 380
MTOR inhibitors as a new therapeutic option for epilepsy 376
Paediatric use of melatonin (Author reply to D. J. Kennaway). 370
Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations. 368
Early control of seizures improves long-term outcome in children with tuberous sclerosis complex 366
Can we change the course of epilepsy in tuberous sclerosis complex? 352
Syndrome of Transient Headache and Neurologic Deficits With Cerebrospinal Fluid Lymphocitosis Should Be Considered in Children Presenting With Acute Confusional State 352
New perspectives in Autism spectrum disorder associated with tuberous sclerosis 344
Vagus nerve stimulation for refractory epilepsy in tuberous sclerosis. 317
Management of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations 311
Pharmacotherapy of idiopathic generalized epilepsies 308
Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsy 306
Neuroimaging findings of Sturge-Weber Syndrome in a child with Tuberous Sclerosis 305
Recent advances in neurobiology of Tuberous Sclerosis Complex 287
A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND) 283
Autism spectrum disorder and 3p24.3p23 triplication: a case report 274
A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: A Delphi consensus report 206
Early Clinical Predictors of Autism Spectrum Disorder in Infants with Tuberous Sclerosis Complex: Results from the EPISTOP Study 201
mTOR dysregulation and tuberous sclerosis-related epilepsy 196
Everolimus for Retinal Astrocytic Hamartomas in Tuberous Sclerosis Complex 190
Restless legs syndrome and growing pains in childhood: understanding the link 173
Cyclic vomiting syndrome and benign paroxysmal torticollis are associated with a high risk of developing primary headache: A longitudinal study 170
Clinical Features of Pediatric Idiopathic Intracranial Hypertension and Applicability of New ICHD-3 Criteria 165
Sleep-related painful erection: the first case in a child 160
Features of primary chronic headache in children and adolescents and validity of ICHD 3 criteria 160
Prophylactic treatment of pediatric migraine: Is there anything new in the last decade? 154
Immediate and prolonged-release melatonin in children with neurodevelopmental disabilities. Author reply to Prof. Zisapel 153
Is autism driven by epilepsy in infants with Tuberous Sclerosis Complex? 144
Safety of SARS-CoV2 vaccination and COVID-19 short-term outcome in pediatric acquired demyelinating disorders of central nervous system: A single center experience 137
Case Report: Migralepsy: The Two-Faced Janus of Neurology 137
Tolerability of palmitoylethanolamide in a pediatric population suffering from migraine: a pilot study 134
Sleep disturbances and behavioral symptoms in pediatric Sotos syndrome 131
Subacute Sclerosing Panencephalitis in Children: The Archetype of Non-Vaccination 128
Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial 121
Clinical Variability of Pediatric MERS: Insights from a Retrospective Observational Study 119
Restless sleep disorder in a sample of children and adolescents with autism spectrum disorder: preliminary results from a case series 118
Primary Headaches and Sleep Disorders: Review of Literature about Comorbidity in Children and Adolescents 117
Benign Intracranial Hypertension Due to Hypoparathyroidism: A Case Report 115
Diagnosis of pediatric anti-NMDAR encephalitis at the onset: A clinical challenge 114
Pediatric Neuromyelitis Optica Spectrum Disorder: Case Series and Literature Review 112
Anxiety, Depression, and Body Weight in Children and Adolescents With Migraine 112
Autism and epilepsy in patients with Tuberous Sclerosis Complex 111
Questionnaire-based assessment of sleep disorders in an adult population of Tuberous Sclerosis Complex 108
Sleep Disorders in Pediatric Migraine: A Questionnaire-Based Study 105
A Case Report of Pediatric Patient with Tuberous Sclerosis and Radiologically Isolated Syndrome 105
Long-Term Effects of COVID-19 Pandemic on Migraine in Adolescents. A Retrospective Analysis of the Population Attending the Headache Center in Different Phases of the Pandemic 95
I stay at home with headache. A survey to investigate how the lockdown for COVID-19 impacted on headache in Italian children 95
Early epileptiform EEG activity in infants with tuberous sclerosis complex predicts epilepsy and neurodevelopmental outcomes 93
Sleep disorders and neuropsychiatric disorders in a pediatric sample of tuberous sclerosis complex: a questionnaire-based study 86
Screen exposure and sleep: How the COVID-19 pandemic influenced children and adolescents - A questionnaire-based study 84
High Intellectual Potential and High Functioning Autism: Clinical and Neurophysiological Features in a Pediatric Sample 84
Genetic pathogenesis of the epileptogenic lesions in Tuberous Sclerosis Complex: Therapeutic targeting of the mTOR pathway 80
Sleep Disorders in a Sample of Patients with Pediatric-Onset Multiple Sclerosis: Focus on Restless Legs Syndrome 79
Prenatal mTOR Inhibitors in Tuberous Sclerosis Complex: Current Insights and Future Directions 79
miRNAs and isomiRs: Serum-Based Biomarkers for the Development of Intellectual Disability and Autism Spectrum Disorder in Tuberous Sclerosis Complex 79
Event-Related Potentials in ADHD Associated With Tuberous Sclerosis Complex: A Possible Biomarker of Symptoms Severity? 79
Surgery for drug-resistant tuberous sclerosis complex-associated epilepsy: who, when, and what 78
Interictal Cognitive Performance in Children and Adolescents With Primary Headache: A Narrative Review 77
Case report: A pediatric case of Bickerstaff brainstem encephalitis after COVID-19 vaccination and Mycoplasma pneumoniae infection: Looking for the culprit 77
Migraine and Its Equivalents: What Do They Share? A Narrative Review on Common Pathophysiological Patterns 77
Medication Overuse Withdrawal in Children and Adolescents Does Not Always Improve Headache: A Cross-Sectional Study 76
How to Assess the Headache—Sleep Disorders Comorbidity in Children and Adolescents 74
Totale 26.972
Categoria #
all - tutte 77.964
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.964


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022615 0 0 0 9 18 62 25 21 159 54 52 215
2022/2023848 96 89 17 81 79 232 87 35 67 3 39 23
2023/2024407 42 9 21 3 28 97 8 3 2 12 96 86
2024/20252.821 57 662 353 153 80 178 140 101 140 452 254 251
2025/20264.516 298 193 482 270 496 141 566 558 492 330 350 340
2026/20271.561 325 271 739 226 0 0 0 0 0 0 0 0
Totale 28.030